Coloplast A/S

Coloplast A/S

COLO-B · CO · Healthcare / Medical Instruments & Supplies

508.00DKK+13.90 (+2.81%)

Price History

Full chart

Market Stats

Previous Close494.10
Open496.50
Day Range494.10 – 508.00
52-Week Range369.70 – 604.41
Volume297.51K
Market Cap108.70B
P/E (TTM)39.34
Forward P/E17.92
EPS12.26
Dividend Yield4.77%
Beta0.56
50-Day Avg445.50
200-Day Avg436.18

About

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Gavin Wood
  • Employees17.21K
  • HeadquartersHoltedam 1-3, Humlebæk, Denmark, 3050, Denmark
  • Websitehttps://www.coloplast.com

Leadership

  • Mr. Anders Lonning-SkovgaardExecutive VP & CFO · b. 1972
  • Mr. Allan RasmussenExecutive Vice President of Global Operations · b. 1967
  • Mr. Nicolai Buhl AndersenExecutive Vice President of Chronic Care · b. 1969
  • Mr. Thomas BarfodSenior Controller & Employees Representative Director · b. 1970
  • Mr. Gavin WoodPresident & CEO · b. 1971
  • Aleksandra DimovskaVice President of Investor Relations
  • Mr. Dennis KaysenVice President of Corporate Communications
  • Ms. Amanda RajkumarExecutive VP & Chief People Officer · b. 1972
  • Mr. Alain MorvanSenior Vice President of Sales Europe
  • Ms. Caroline Vagner RosenstandExecutive Vice President of Chronic Care Commercial · b. 1979

Financials

Income Statement

Currency: DKK2002-09-302003-09-302004-09-302005-09-302006-09-302007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Revenue5.62B5.67B6.07B6.23B6.71B8.04B8.46B8.82B9.54B10.17B11.02B11.63B12.43B13.91B14.68B15.53B16.45B17.94B18.54B19.43B22.58B24.50B27.03B27.87B
Growth (%)-+0.80%+7.12%+2.63%+7.65%+19.87%+5.24%+4.22%+8.13%+6.66%+8.37%+5.55%+6.82%+11.92%+5.55%+5.77%+5.93%+9.06%+3.37%+4.76%+16.23%+8.51%+10.33%+3.12%
Cost of Revenue2.21B2.16B2.34B2.44B1.69B1.95B3.46B3.72B3.69B3.60B3.68B3.77B3.89B4.38B4.65B4.96B5.38B5.79B5.93B6.11B7.05B8.17B8.76B9.74B
Gross Profit3.41B3.51B3.74B3.79B5.02B6.10B5.00B5.10B5.84B6.57B7.34B7.87B8.54B9.53B10.03B10.57B11.07B12.15B12.61B13.31B15.53B16.33B18.27B18.14B
Gross Margin60.69%61.95%61.52%60.80%74.85%75.81%59.06%57.86%61.28%64.57%66.63%67.61%68.70%68.54%68.33%68.08%67.27%67.75%68.01%68.53%68.78%66.64%67.59%65.06%
Operating Expense1.95B2.58B2.74B2.79B4.14B5.35B4.00B3.71B3.85B3.99B4.09B4.19B5.39B5.02B5.94B5.55B5.97B7.00B6.76B6.96B9.09B9.56B10.95B10.56B
Operating Income1.47B931.00M997.18M1.00B879.00M749.00M994.00M1.40B2.00B2.58B3.25B3.67B3.15B4.52B4.10B5.02B5.09B5.16B5.85B6.36B6.44B6.77B7.32B7.58B
Operating Margin26.05%16.42%16.42%16.05%13.10%9.31%11.75%15.82%20.92%25.37%29.53%31.56%25.32%32.47%27.90%32.35%30.95%28.74%31.57%32.71%28.52%27.64%27.08%27.19%
EBITDA1.77B1.49B1.13B1.34B1.24B1.34B1.71B1.92B2.60B3.10B3.55B4.16B3.64B1.76B4.65B5.61B5.68B5.68B6.35B7.08B7.23B7.73B8.57B8.34B
EBITDA Margin31.54%26.21%18.63%21.50%18.44%16.63%20.25%21.77%27.28%30.47%32.18%35.78%29.32%12.67%31.69%36.12%34.51%31.69%34.23%36.46%32.02%31.56%31.69%29.91%
Net Income768.00M561.00M587.89M553.00M466.00M370.00M715.00M883.00M1.24B1.82B2.19B2.71B2.39B899.00M3.14B3.80B3.85B3.87B4.20B4.83B4.71B4.78B5.05B3.64B
Net Income Margin13.66%9.90%9.68%8.87%6.95%4.60%8.45%10.01%13.03%17.88%19.90%23.30%19.23%6.46%21.41%24.45%23.38%21.59%22.63%24.84%20.84%19.52%18.69%13.04%
R&D173.00M168.00M200.92M215.00M97.00M135.00M415.00M389.00M409.00M415.00M342.00M380.00M390.00M442.00M509.00M574.00M640.00M692.00M708.00M755.00M866.00M872.00M866.00M900.00M
R&D as % of Total Revenue3.08%2.96%3.31%3.45%1.45%1.68%4.90%4.41%4.29%4.08%3.10%3.27%3.14%3.18%3.47%3.70%3.89%3.86%3.82%3.89%3.84%3.56%3.20%3.23%
Interest Expense229.00M310.00M132.00M156.00M155.00M184.00M203.00M245.00M339.00M171.00M91.00M49.00M25.00M31.00M41.00M45.00M44.00M54.00M63.00M57.00M240.00M719.00M882.00M825.00M
Interest Expense % of Total Revenue4.07%5.47%2.17%2.50%2.31%2.29%2.40%2.78%3.55%1.68%0.83%0.42%0.20%0.22%0.28%0.29%0.27%0.30%0.34%0.29%1.06%2.93%3.26%2.96%

Balance Sheet

Currency: DKK2002-09-302003-09-302004-09-302005-09-302006-09-302007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Total Assets4.49B5.36B5.64B5.92B7.98B7.75B7.98B7.96B7.77B9.22B10.18B9.36B10.38B10.82B11.01B12.05B11.77B12.73B13.50B15.84B34.96B48.16B48.07B48.37B
Total Liabilities2.92B3.35B3.27B3.40B5.18B5.35B5.69B5.11B4.32B4.74B4.13B2.60B4.10B6.11B5.94B6.10B5.35B5.82B6.09B7.67B26.66B30.86B30.13B32.24B
Total Equity1.56B2.00B2.35B2.51B2.80B2.40B2.29B2.85B3.45B4.48B6.04B6.77B6.28B4.71B5.07B5.95B6.42B6.91B7.41B8.17B8.29B17.30B17.94B16.12B
Cash320.00M623.00M736.72M1.10B149.00M273.00M193.00M629.00M475.00M1.32B1.97B1.50B971.00M881.00M546.00M314.00M297.00M356.00M323.00M448.00M414.00M911.00M788.00M947.00M
Total Debt1.79B2.30B-1.80B2.99B3.10B3.27B2.49B172.00M2.09B1.30B111.00M92.00M100.00M222.00M1.46B1.36B1.21B1.75B2.79B18.71B19.57B22.63B22.64B
Net Debt1.47B1.68B-736.72M699.00M2.84B2.82B3.08B1.86B-303.00M776.00M-677.00M-1.39B-879.00M-781.00M-324.00M1.14B1.06B852.00M1.42B2.34B18.29B18.66B21.84B21.69B

Cash Flow

Currency: DKK2002-09-302003-09-302004-09-302005-09-302006-09-302007-09-302008-09-302009-09-302010-09-302011-09-302012-09-302013-09-302014-09-302015-09-302016-09-302017-09-302018-09-302019-09-302020-09-302021-09-302022-09-302023-09-302024-09-302025-09-30
Operating Cash Flow913.00M911.00M840.90M1.35B966.00M1.00B1.32B1.83B1.77B2.21B2.65B3.14B3.15B3.34B3.03B3.25B4.36B4.36B4.76B5.29B5.10B4.23B2.77B6.64B
Investing Cash Flow-878.00M-783.00M-617.65M-434.00M-2.99B95.00M-671.00M-402.00M-293.00M-387.00M-313.00M-437.00M-777.00M-468.00M-603.00M-1.62B-947.00M-591.00M-901.00M-2.01B-11.76B-8.96B-1.34B-1.25B
Financing Cash Flow1.05B307.00M-238.13M-446.00M782.00M-1.42B-469.00M-723.00M-1.56B-894.00M-1.73B-3.43B-2.90B-2.96B-2.87B-1.86B-3.43B-3.71B-3.86B-3.18B6.59B5.26B-1.52B-5.19B
Capital Expenditure500.00M804.00M401.85M459.00M457.00M596.00M623.00M417.00M306.00M250.00M338.00M440.00M533.00M617.00M649.00M685.00M669.00M636.00M931.00M1.97B1.14B1.24B1.17B1.31B
Free Cash Flow413.00M107.00M439.05M894.00M509.00M408.00M701.00M1.41B1.46B1.96B2.31B2.70B2.62B2.72B2.38B2.57B3.69B3.72B3.83B3.32B3.96B2.98B1.60B5.34B
Dividends Paid85.00M102.00M119.07M140.00M162.00M184.00M396.00M257.00M300.00M422.00M587.00M1.48B2.32B2.54B2.65B2.86B3.29B3.40B3.61B3.83B4.04B4.25B4.72B4.96B
FCF to OCF45.24%11.75%52.21%66.08%52.69%40.64%52.95%77.21%82.70%88.66%87.24%85.97%83.07%81.51%78.57%78.93%84.66%85.40%80.44%62.84%77.74%70.63%57.85%80.35%
Dividend Paid to FCF20.58%95.33%27.12%15.66%31.83%45.10%56.49%18.19%20.51%21.59%25.40%54.75%88.69%93.20%111.39%111.61%89.06%91.32%94.36%115.22%101.94%142.28%295.00%92.86%

Earnings

Report DateNov 18, 2003Aug 20, 2004Nov 17, 2004Feb 10, 2005May 18, 2005Aug 19, 2005Nov 16, 2005Feb 10, 2006May 16, 2006Aug 17, 2006Nov 15, 2006Feb 8, 2007May 15, 2007Aug 16, 2007Nov 20, 2007Feb 19, 2008May 21, 2008Aug 21, 2008Nov 19, 2008Feb 3, 2009May 5, 2009Aug 14, 2009Nov 6, 2009Jan 28, 2010Apr 29, 2010Aug 19, 2010Nov 3, 2010Jan 25, 2011May 4, 2011Aug 17, 2011Nov 1, 2011Jan 25, 2012Apr 26, 2012Aug 15, 2012Nov 6, 2012Jan 30, 2013Apr 30, 2013Aug 13, 2013Oct 31, 2013Jan 29, 2014May 7, 2014Aug 13, 2014Oct 30, 2014Jan 29, 2015May 5, 2015Aug 11, 2015Nov 3, 2015Feb 2, 2016May 3, 2016Aug 16, 2016Nov 2, 2016Feb 1, 2017May 3, 2017Aug 16, 2017Nov 2, 2017Feb 1, 2018May 3, 2018Aug 8, 2018Nov 1, 2018Feb 5, 2019May 2, 2019Aug 14, 2019Nov 5, 2019Feb 5, 2020May 6, 2020Aug 18, 2020Nov 3, 2020Feb 2, 2021May 6, 2021Aug 18, 2021Nov 1, 2021Jan 25, 2022May 5, 2022Aug 17, 2022Nov 7, 2022Feb 3, 2023May 11, 2023Aug 17, 2023Nov 9, 2023Feb 9, 2024May 7, 2024Aug 20, 2024Nov 5, 2024Feb 4, 2025May 6, 2025Aug 19, 2025Nov 4, 2025Feb 6, 2026May 12, 2026Aug 18, 2026Nov 3, 2026
EPS Estimate-0.670.690.630.620.720.790.730.670.530.300.660.920.860.871.040.910.94-0.910.991.101.201.251.241.35-1.961.942.09-2.442.482.863.023.033.113.393.513.493.513.874.034.033.923.654.064.334.314.534.724.444.544.764.894.554.544.855.064.694.785.115.445.055.084.764.995.315.625.735.835.705.546.136.016.506.166.156.295.675.866.035.825.765.945.257.056.075.846.055.73
EPS Actual0.640.800.800.400.660.810.820.600.801.010.200.620.291.35-0.251.000.731.280.300.961.131.001.501.281.421.631.741.921.842.282.532.592.512.922.862.882.953.303.493.633.443.694.243.743.823.324.313.874.314.604.754.464.384.624.754.424.324.474.894.664.785.025.185.125.004.674.885.336.035.886.125.785.996.135.925.355.515.885.725.455.635.795.476.385.454.934.676.32-0.166.55-
Surprise-19.40%15.94%-36.51%6.45%12.50%3.80%-17.81%19.40%90.57%-33.33%-6.06%-68.48%56.98%-128.74%-3.85%-19.78%36.17%-5.49%14.14%-9.09%25.00%2.40%14.52%20.74%--2.04%-5.15%9.09%-6.15%1.21%2.10%-5.30%-4.95%-5.14%-2.65%-0.57%4.01%-1.99%-4.65%5.21%-7.20%-2.55%-9.04%6.16%-10.62%0.00%1.55%0.64%0.45%-3.52%-2.94%-2.86%-2.86%-4.85%-7.84%-3.36%-0.64%0.00%-1.76%-4.78%1.39%-1.57%-1.89%-2.20%0.38%7.30%2.62%4.97%1.40%8.12%0.00%-1.50%-17.69%-10.55%-4.39%-9.06%-3.88%-3.92%-3.98%-6.01%10.76%-8.25%-6.10%-33.76%4.12%-102.74%8.26%-
Timing-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hours

Key Statistics & Ratios

Market Cap108.70B
Enterprise Value131.68B
Trailing P/E39.34
Forward P/E17.92
PEG Ratio1.23
Price / Sales3.82
Price / Book8.13
EPS12.26
Book Value59.37
Revenue (TTM)28.44B
Gross Profit (TTM)19.12B
EBITDA8.63B
Profit Margin9.72%
Operating Margin26.23%
Return on Equity18.53%
Return on Assets10.12%
Shares Outstanding207.37M
Shares Float144.57M
Beta0.56
Dividend Yield4.77%
Dividend Rate23.00
Payout Ratio1.81%

Dividends

20261×
5.00May 18, 2026
20252×
18.00Dec 5, 20255.00May 8, 2025
20242×
17.00Dec 6, 20245.00May 13, 2024
20232×
16.00Dec 8, 20235.00May 15, 2023
20222×
15.00Dec 2, 20225.00May 9, 2022
20212×
14.00Dec 3, 20215.00May 10, 2021
20202×
13.00Dec 4, 20205.00May 11, 2020
20192×
12.00Dec 6, 20195.00May 6, 2019
20182×
11.00Dec 6, 20185.00May 7, 2018
20172×
10.50Dec 8, 20174.50May 8, 2017
20162×
9.00Dec 6, 20164.50May 9, 2016
20152×
8.00Dec 10, 20154.50May 7, 2015
20141×
7.50Dec 5, 2014

Stock Splits

  • Dec 19, 20125:1
  • Dec 16, 20042:1
  • Jan 19, 20002:1
  • Jan 29, 199750081:33387
  • Jan 20, 199450081:33387
  • Mar 24, 19935:1